All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
09/20/22	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	10
09/19/22	4	Statement of changes in beneficial ownership of securities	1
09/19/22	4	Statement of changes in beneficial ownership of securities	1
09/19/22	4	Statement of changes in beneficial ownership of securities	1
09/19/22	4	Statement of changes in beneficial ownership of securities	1
09/19/22	4	Statement of changes in beneficial ownership of securities	1
09/19/22	4	Statement of changes in beneficial ownership of securities	1
09/19/22	4	Statement of changes in beneficial ownership of securities	1
09/19/22	4	Statement of changes in beneficial ownership of securities	1
09/19/22	4	Statement of changes in beneficial ownership of securities	1